COMMUNIQUÉS West-GlobeNewswire

William Demant Holding A/S: Interim Management Statement covering the period year-to-date
08/05/2018
Company announcement no 2018-06 8 May 2018 Continued strong performance by the Group in line with our expectations Innovative products driving strong organic growth in hearing aid wholesale business 2018 outlook [...]
Lundbeck realized 14% growth in revenue (local currency) and 103% growth in EPS
08/05/2018
HIGHLIGHTS Revenue reached DKK 4,585 million in the first quarter of 2018 representing an increase of 9% (14% in local currencies) compared to the same period in 2017 Revenue of Abilify Maintena ® increased 15% to DKK [...]
DBV Technologies to Present New Clinical Data from Viaskin Platform at the 2018 EAACI Meeting
08/05/2018
Montrouge, France, May 8, 2018 DBV Technologies to Present New Clinical Data from Viaskin Platform at the 2018 EAACI Meeting Results from positive Phase II study of second product candidate, Viaskin Milk, to be [...]
DBV Technologies présentera de nouvelles données cliniques concernant la plateforme Viaskin lors du Congrès EAACI 2018
08/05/2018
Montrouge, France, le 8 mai (07h30 CEST), 2018 DBV Technologies présentera de nouvelles données cliniques concernant la plateforme Viaskin lors du Congrès EAACI 2018 Les résultats de l'étude positive de phase II du [...]
PCI Biotech: First quarter 2018 report and presentation
08/05/2018
Oslo (Norway), 8 May 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim first quarter 2018 result. Please find enclosed the Q1 2018 report and presentation. The dose- [...]
US FDA APPROVES USE OF VELTASSA® WITH OR WITHOUT FOOD
08/05/2018
Updated label may allow for increased dosing flexibility for patients with hyperkalaemia Label update effective immediately in the US THE UNITED STATES (us) FOOD AND DRUG ADMINISTRATION (fda) HAS APPROVED A SUPPLEMENTAL [...]
TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHOLDERS' MEETING TO BE HELD ON 7 JUNE 2018
08/05/2018
TiGenix Limited liability company that makes or has made a public call on savings Romeinse straat 12 box 2 3001 Leuven VAT BE 0471.340.123 RLE Leuven CONVENING NOTICE TO the ANNUAL shareholders' meeting to be held on 7 [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
08/05/2018
REGULATED INFORMATION GHENT, Belgium, 8 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018
08/05/2018
Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018 HALLE (SAALE), Germany, 8 May 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]
Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program
08/05/2018
Results confirm LPS Antagonist action of IMM-124E offers a novel therapeutic approach to induce or maintain remission in IBD MELBOURNE, Australia, May 07, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN [...]
MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal
08/05/2018
LA JOLLA, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday, May 8, 2018
08/05/2018
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43 rd Annual Health Care Conference. The [...]
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma
08/05/2018
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for [...]
MacroGenics to Present at Deutsche Bank Health Care Conference
08/05/2018
ROCKVILLE, MD, May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Genesis Healthcare Expects to Release First Quarter 2018 Results on May 10, 2018
07/05/2018
KENNETT SQUARE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results
07/05/2018
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2018
SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Amedisys Reports First Quarter 2018 Financial Results and Reaffirms 2018 Guidance
07/05/2018
BATON ROUGE, La., May 07, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three month period ended March 31, 2018. Three Month Periods Ended March 31, 2018 and 2017 [...]
Loxo Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2018
STAMFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, [...]

Pages